How Will the Market React to Dynavax Technologies Corp (DVAX) Stock Getting a Bearish Rating

Dynavax Technologies Corp (DVAX) stock has fallen 0.84% over the past week and gets a Bearish rating from InvestorsObserver Sentiment Indicator.

Dynavax Technologies Corp has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on DVAX!

See Full DVAX Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With DVAX Stock Today?

Dynavax Technologies Corp (DVAX) stock has gained 1.51% while the S&P 500 is lower by -0.72% as of 11:52 AM on Thursday, Oct 26. DVAX is up $0.21 from the previous closing price of $13.94 on volume of 186,668 shares. Over the past year the S&P 500 has risen 7.71% while DVAX is up 24.78%. DVAX earned $0.70 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 20.27. To see InvestorsObserver's Sentiment Score for Dynavax Technologies Corp click here.

More About Dynavax Technologies Corp

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of hepatitis B. Dynavax operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product. Click Here to get the full Stock Report for Dynavax Technologies Corp stock.